As part of the ICBP SURVMARK-2 project, several mechanisms will be implemented to encourage expertise transfer.
Dr Morgan investigated survival differences in oesophageal cancer under the Expertise Transfer for ICBP SurvMark-2 at IARC. The proposed project focused on investigating survival differences in oesophageal cancer by treatment, histological subtype, stage at diagnoses and period of diagnosis across different jurisdictions. The project also covered investigating variations in survival as a result of differences in terms of registration practice regarding death certificate-initiated registrations.
Dr Morgan's testimonial: “The Expertise Transfer Scheme has allowed me to gain invaluable experience in working on a collaborative, international partnership and to build and develop skills in the analyses of international data whilst contributing to the aims of ICBP to improve the lives of cancer patients”
Mr Abd Elkader's project ‘A study of avoidable premature deaths in cancer patients’ under the Expertise Transfer for ICBP SurvMark-2 at IARC will study avoidable deaths for the eight ICBP cancer sites (colon, rectum, lung, ovary, oesophagus, stomach, pancreas and liver) as well as melanoma of the skin. This research will focus on determining how many premature deaths might have been avoided if cancer survival differences, between ICBP jurisdictions, are reduced. The project will also try to assess the proportionate distribution of avoidable deaths in Māori and non-Māori cancer patients.
The second round of Expertise Transfer Scheme has been awarded to Tanya Navaneelan and Guillaume Ruel. They will be hosted at IARC mid-2019.
Tanya Navaneelan will be looking into the impact of colorectal cancer screening on survival estimates in Ontario compared to other jurisdictions. The results of this could be valuable in improving cancer surveillance practices in Ontario and provide a baselines for Ontario’s new lung cancer screening programme. Guillaume Ruel will be investigating the change in registration practices and the effect of this on survival estimates in Canadian jurisdictions. This should enable greater understanding of the impact of different sources of cancer information on the precision of recording cancer subtypes, and the overall impact on survival analyses.
Collaborations with researchers having their own fellowships or other funding for a research visit are also welcome. Participation in both schemes is subject to strict confidentiality policies. Beneficiaries of any expertise transfer scheme must follow the general IARC rules and sign a confidentiality agreement covering data use.
Outputs of the ICPB SURVMARK-2 project and their impact will be highlighted during international summits and conferences in order to exchange information with interested researchers and policy-makers.